<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
    	<title>IJPRS/V5/I4/00143 - 30/10/2016</title>

	<item>
		<title>Formulation Development and Evaluation of Nepafenac Novel In Situ Gel</title>
		
		<description><![CDATA[<h5>Author's Affiliation</h5>
		                                                <p></p>
		                                                <hr/>
                                                    	<h5>Abstract</h5>
		                                                <p>The aim of present study was to formulate and evaluate Nepafenac liposomal <em>in situ</em> gel. Liposomes were formulated in different ratios using soya lecithin and cholesterol using Rotary Flash Evaporation method. Liposomes were evaluated for drug entrapment efficiency, %entrapment efficiency, particle size analysis, zeta potential and <em>in vitro</em> release studies. Optimized liposomes (F4) were developed into <em>in situ</em> gels. The thermo reversible liposomal <em>in situ</em> gels of Nepafenac were  prepared  by  using  poloxamer  407  and  with mucoadhesive  polymers  like  HPMC  E15 and chitosan. Formulations were sterilized by autoclaving at 121⁰C, at 15 lb pressure for 20 min. The formulations were  evaluated  for  drug  content,  clarity,  pH, gelation temperature,  gelation  capacity,  viscosity,  <em>in-vitro  </em>drug  release studies. Drug and Polymer incompatibilities were evaluated using FTIR spectrophotometer. The drug content of the formulations was in the range 83%-92%. pH of the formulations was in the range 6.43 to 7.42, gelation temperature was in the range 27.5⁰C-40⁰C. <em>In Vitro</em> drug release was in the range of 78%-99% within 12 hours, the extent of gelation and consequently the release of Nepafenac depended on the concentration of polymers used. Nepafenac was released slowly from gels, for a period of 12 hours. Formulation PC5 with poloxamer 407 (18% w/w) and chitosan (0.3% w/w) was found to be suitable as it released 78% of drug for a period of 12 hours. Poloxamer 407/chitosan (PC5) combination was found to have optimum pH and gelation temperature which is required for an <em>in situ</em> gel drug delivery system.</p>
                                                    	<hr/>
                                                        <h5>Keywords</h5>
                                                         <p><em>In Situ</em> Gel, Liposomes, Entrapment Efficiency, Zeta Potential</p>
                                                         
                                                    	                                                    	<hr/>
                                                         <h5>Cite This Article</h5>
                                                         <p>Nalla, A., Panigrahy, R.N., Chinnala, K.M. (2016). Formulation Development and Evaluation of Nepafenac Novel <em>In Situ</em> Gel, <em>International Journal for Pharmaceutical Research Scholars (IJPRS)</em>, 5(4), 1-14.</p>                                                         <hr/>
                                                         <p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fformulation-development-and-evaluation-of-nepafenac-novel-in-situ-gel%2F&amp;linkname=Formulation%20Development%20and%20Evaluation%20of%20Nepafenac%20Novel%20In%20Situ%20Gel" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fformulation-development-and-evaluation-of-nepafenac-novel-in-situ-gel%2F&amp;linkname=Formulation%20Development%20and%20Evaluation%20of%20Nepafenac%20Novel%20In%20Situ%20Gel" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fformulation-development-and-evaluation-of-nepafenac-novel-in-situ-gel%2F&#038;title=Formulation%20Development%20and%20Evaluation%20of%20Nepafenac%20Novel%20In%20Situ%20Gel" data-a2a-url="https://www.ijprs.com/article/formulation-development-and-evaluation-of-nepafenac-novel-in-situ-gel/" data-a2a-title="Formulation Development and Evaluation of Nepafenac Novel In Situ Gel"></a></p>]]>
        </description>
		<link>https://www.ijprs.com/article/formulation-development-and-evaluation-of-nepafenac-novel-in-situ-gel/</link>
		<author>Nalla, A., Panigrahy, R.N., Chinnala, K.M.        </author>

		<pdflink>http://www.ijprs.com/wp-content/uploads/2018/09/IJPRS-V5-I4-00143.pdf</pdflink>

	</item>
</channel>
</rss>
